MTIH Welcomes Daniele Pasatieri as New Executive Director

The Metabolic Terrain Institute of Health (MTIH) is proud to announce that Daniele Pasatieri, MHA, BSN, RN, will assume the role of Executive Director on February 17, 2025. This appointment marks an exciting new chapter for MTIH as the organization continues to advance its mission of restoring health through Research, Education, Access, Community, and Hope.

Daniele Pasatieri brings over 25 years of innovation and leadership in oncology care. Her impressive career includes a proven track record of advancing cancer research, overseeing complex programs, and driving transformative outcomes. As Administrative Director of the Blood & Marrow Transplant Program at HCA/Medical City Dallas and Medical City Children's Hospitals, she led significant advancements, including a 122% increase in transplant volume, the establishment of cutting-edge services in cellular therapy, and the development of strategic partnerships to improve patient outcomes. Her expertise spans regulated environments, operational leadership, and fostering collaborative innovation.

In addition to her professional accomplishments, Daniele’s connection to MTIH’s mission is deeply personal. As a current student in MTIH’s Terrain Advocate Program and a cancer thriver, she has experienced firsthand the transformative power of the Metabolic Approach to Cancer. After being diagnosed with colorectal cancer in late 2023, she embraced integrative, metabolic-focused care as part of her healing journey. This experience has fortified her belief in addressing root causes, empowering patients, and creating sustainable, life-affirming solutions.

“My diagnosis was life-altering, but it awakened a purpose that has reshaped how I view health and healing," she said. "MTIH embodies everything I believe about addressing the terrain, restoring balance, and providing hope for individuals facing life’s greatest challenges. It’s an honor to join this mission and contribute to the transformative work this organization is doing.”

This announcement comes at a pivotal time for MTIH. Earlier this year, MTIH opened a state-of-the-art research and development laboratory in Phoenix, Arizona. This milestone expanded the organization’s capabilities in studying therapies that directly target metabolic dysfunction. As MTIH enters the next phases for the lab—focusing on cellular uptake, biomarker discovery, and innovative clinical studies—Daniele’s extensive experience in laboratory operations, regulated industries, and research strategy will be instrumental in driving these efforts forward.

Dr. Nasha Winters, ND, FABNO, MTIH Co-Founder, and current Executive Director, expressed her excitement for this transition.

“Daniele’s expertise in laboratory operations and research, coupled with her unwavering commitment to empowering patients, makes her the ideal leader to guide MTIH into this exciting new phase,” Dr. Winters said. “Her personal journey and professional accomplishments embody the very spirit of our mission.”

Dr. Winters will remain actively involved with MTIH as Co-Founder, continuing to guide the organization’s vision and mission.

Daniele’s unique blend of professional expertise, personal experience, and passion for integrative health aligns perfectly with MTIH’s mission. Her leadership will undoubtedly propel MTIH into an even brighter future, advancing its transformative work to restore health for those navigating cancer and other metabolic diseases.